Contents of this document
- Exchange rate (yen/US dollar)150
- Exchange rate (yen/euro)175
- Testing in preparation for registration of the new insecticide NI-40
- Diversification of raw material and fuel sources
- Revisions to selling prices to reflect increases in raw material and fuel prices
- Discontinuation of sales of sodium cyanide, the water treatment agent Nisso Hyclone and other products
- Net income per share¥336.5 per shareYear on year against the same period last yearup 23.5% year on year
- Overseas sales ratio (Agribusiness)65.7 %Year on year against the same period last yearup 0.9 percentage points year on year
- Equity ratio66.6 %Year on year against the same period last yearup 1.8 percentage points year on year
- Debt-to-equity ratio0.26 timesPrior-year period0.27x
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Fiscal year ending March 2026, full year |
| Net Sales | 1,520.9 Hundreds of millions of yen (YoY -2.0%) |
| Operating profit | 149.7 Hundreds of millions of yen (YoY -6.8%) |
| Ordinary income | 229.9 Hundreds of millions of yen (YoY +17.7%) |
| Net income | 182.7 Hundreds of millions of yen (YoY +21.7%) |
| Operating profit margin | 9.8% (the graph shows a decline from 9.8% to 7.2% year on year) |
| Full-year earnings forecast | Net Sales 1,522 Hundreds of millions of yen / Operating profit 142 Hundreds of millions of yen / Ordinary income 190 Hundreds of millions of yen / Profit attributable to owners of the parent 158 Hundreds of millions of yen / Earnings per share ¥294.8 per share |
| Segment results | Chemical Materials Net Sales ¥37,410 million (up 2.6% year on year) / Operating profit ¥5,720 million (down 5.8% year on year) / Agribusiness Net Sales ¥52,500 million (down 2.0% year on year) / Operating profit ¥5,490 million (up 7.2% year on year) / Trading & Logistics Net Sales ¥43,810 million (up 2.3% year on year) / Operating profit ¥2,270 million (down 6.1% year on year) / Engineering Net Sales ¥8,520 million (down 35.2% year on year) / Operating profit ¥1,140 million (down 51.8% year on year) / Eco Solutions Net Sales ¥9,860 million (up 7.0% year on year) / Operating profit ¥530 million (up 432.7% year on year) |
| Breakdown of Factors Affecting the Change | The chart shows the factors behind the change in operating profit, including price variance, volume variance, raw material price variance, other factors and foreign exchange variance, with amounts. Consolidated operating profit decreased by ¥1,090 million year on year. |
| Key KPIs | Indicator name Net income per share / Value ¥336.5 per share / Year on year against the same period last year up 23.5% year on year, Indicator name Overseas sales ratio (Agribusiness) / Value 65.7 % / Year on year against the same period last year up 0.9 percentage points year on year, Indicator name Equity ratio / Value 66.6 % / Year on year against the same period last year up 1.8 percentage points year on year, Indicator name Debt-to-equity ratio / Value 0.26 times / Prior-year period 0.27x |
| Assumptions Underlying the Business Outlook | Item Exchange rate (yen/US dollar) / Value 150, Item Exchange rate (yen/euro) / Value 175 |
| Annual Dividend | ¥160 per share (illustrated values for actual FY March 2026 and forecast FY March 2027) |
| Payout ratio | 47.5% for FY March 2026 and a forecast 54.3% for FY March 2027. Total payout ratio was 74.6% for FY March 2026. |
| Acquisition of treasury shares | ¥5,000 million (May 2025–January 2026). All repurchased shares have been canceled. |
| Capital expenditures | 107 (actual FY March 2026), 220 (forecast FY March 2027) |
| New initiatives | Testing in preparation for registration of the new insecticide NI-40, Diversification of raw material and fuel sources, Revisions to selling prices to reflect increases in raw material and fuel prices, Discontinuation of sales of sodium cyanide, the water treatment agent Nisso Hyclone and other products |
Items this document does not state (14)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In FY March 2026, operating profit declined due to lower large-scale plant construction orders in Engineering, a decrease in inventory valuation gains, and higher R&D expenses and depreciation associated with the completion of capacity expansion projects in Chemical Materials. Meanwhile, higher equity-method investment gains, foreign exchange gains and gains on the sale of investment securities lifted ordinary profit and net profit. For FY March 2027, the company expects a decline in inventory valuation gains, lower equity-method investment gains following the reversal of foreign exchange gains recorded in the previous fiscal year, lower selling prices for agrochemicals and higher R&D expenses.